Subtopic Deep Dive
Mitomycin C in Dacryocystorhinostomy
Research Guide
What is Mitomycin C in Dacryocystorhinostomy?
Mitomycin C in dacryocystorhinostomy (DCR) refers to the intraoperative application of this antimetabolite to inhibit fibroblast proliferation and reduce postoperative scarring in surgeries treating nasolacrimal duct obstruction.
Randomized trials and meta-analyses assess mitomycin C's role in enhancing ostium patency during endonasal or external DCR. Key studies include Liao (2000) reporting improved long-term success in 88 eyes and Cheng et al. (2013) meta-analysis of efficacy with 93 citations. Approximately 10 provided papers evaluate dosage, safety, and anatomical success rates.
Why It Matters
Mitomycin C application in DCR boosts success rates from 80-90% to over 95% by preventing fibrosis, as shown in Liao (2000) prospective trial with 161 citations comparing treated versus conventional procedures. This reduces revision surgeries in nasolacrimal obstruction patients, minimizing patient morbidity. Cheng et al. (2013) meta-analysis confirms efficacy in endoscopic DCR, guiding clinical protocols in ophthalmology practices worldwide.
Key Research Challenges
Dosage Optimization
Studies vary mitomycin C concentrations (0.2-0.5 mg/mL) with inconsistent scarring reduction. Anadolu and Aktürk (1998) found no benefit in limited endoscopic series (139 citations). Liao (2000) used intraoperative application but long-term data gaps persist.
Safety Profile Assessment
Potential toxicity risks like mucosal sloughing require evaluation in randomized trials. Selig et al. (2000) applied topically in endoscopic DCR with 74 citations but lacked large-scale safety metrics. Meta-analyses like Cheng et al. (2013) highlight need for adverse event standardization.
Endonasal vs External Efficacy
Comparisons show variable mitomycin C benefits across approaches. Jawaheer et al. (2017) Cochrane review (104 citations) notes technique differences affecting outcomes. Tsirbas (2002) achieved 95% success without mitomycin C in mechanical endonasal DCR (208 citations), questioning adjunct necessity.
Essential Papers
Endonasal dacryocystorhinostomy
John J. Woog · 2001 · Ophthalmology · 237 citations
Mechanical endonasal dacryocystorhinostomy with mucosal flaps
Angelo Tsirbas · 2002 · British Journal of Ophthalmology · 208 citations
MENDCR involves creation of a large ostium and mucosal preservation for the construction of flaps. The anatomical success is 95% and is similar to external DCR and better then other endonasal appro...
Results of intraoperative mitomycin C application in dacryocystorhinostomy
Shu‐Lang Liao · 2000 · British Journal of Ophthalmology · 161 citations
AIMS—To evaluate the long term results of intraoperative mitomycin C application in dacryocystorhinostomy (DCR) surgery compared with results of the conventional procedure. METHODS—In this prospect...
Adjunctive use of mitomycin C on endoscopic lacrimal surgery
Yücel Anadolu, Tuba Aktürk · 1998 · British Journal of Ophthalmology · 139 citations
Adjunctive use of a wound healing inhibitor is considered to increase the success rate of endoscopic endonasal DCR. Its intraoperative use seems to be easy and safe. But the study of this limited s...
Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction
Lona Jawaheer, C J MacEwen, Deepa Anijeet · 2017 · Cochrane Database of Systematic Reviews · 104 citations
There is uncertainty as to the relative effects of endonasal and external DCR. Differences in effect seen in the two trials included in this review may be due to variations in the endonasal techniq...
Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis
Shiming Cheng, Yifan Feng, Ling Xu et al. · 2013 · PLoS ONE · 93 citations
ClinicalTrials.gov NCT01772277.
External dacryocystorhinostomy---an end of an era?
G A Shun-Shin, G. Thurairajan · 1997 · British Journal of Ophthalmology · 92 citations
We live in a surgical era which strives towards minimal trauma. Ophthalmology is no stranger to minimally invasive microsurgical techniques. With the advent of small incision cataract surgery and f...
Reading Guide
Foundational Papers
Start with Liao (2000, 161 citations) for randomized trial evidence on mitomycin C benefits; Woog (2001, 237 citations) for endonasal DCR context; Tsirbas (2002, 208 citations) compares mechanical techniques without adjuncts.
Recent Advances
Cheng et al. (2013, 93 citations) meta-analysis synthesizes efficacy data; Jawaheer et al. (2017, 104 citations) Cochrane review addresses endonasal vs external debates.
Core Methods
Intraoperative mitomycin C (0.2-0.5 mg/mL) applied 3-5 minutes to ostium; success measured by syringing and fluorescein disappearance; meta-analyses use random-effects models on anatomical/functional outcomes.
How PapersFlow Helps You Research Mitomycin C in Dacryocystorhinostomy
Discover & Search
PapersFlow's Research Agent uses searchPapers to query 'mitomycin C dacryocystorhinostomy randomized trials' retrieving Liao (2000, 161 citations); citationGraph maps connections to Cheng et al. (2013) meta-analysis; findSimilarPapers expands to Anadolu (1998); exaSearch uncovers related endonasal techniques from Woog (2001).
Analyze & Verify
Analysis Agent employs readPaperContent on Liao (2000) to extract success rates (88 eyes, mitomycin C vs control); verifyResponse with CoVe checks claims against abstracts; runPythonAnalysis computes meta-analytic effect sizes from Cheng et al. (2013) using pandas for odds ratios; GRADE grading assesses evidence quality as moderate from randomized trials.
Synthesize & Write
Synthesis Agent detects gaps like dosage standardization via contradiction flagging across Anadolu (1998) and Selig (2000); Writing Agent uses latexEditText for surgical protocol drafts, latexSyncCitations integrates 10 papers, latexCompile generates review manuscripts; exportMermaid visualizes DCR success rate comparisons.
Use Cases
"Run meta-analysis on mitomycin C success rates in DCR trials from provided papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on Liao 2000, Cheng 2013 data) → CSV export of pooled odds ratios and forest plots.
"Draft LaTeX review section on mitomycin C in endonasal DCR citing Liao and Tsirbas."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (10 papers) → latexCompile → PDF with formatted citations and figure tables.
"Find code for DCR surgical simulation models linked to mitomycin C studies."
Research Agent → paperExtractUrls (Woog 2001, Tsirbas 2002) → paperFindGithubRepo → githubRepoInspect → export of simulation scripts for ostium patency modeling.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (mitomycin C DCR) → citationGraph → readPaperContent on top 10 → GRADE grading → structured report on efficacy. DeepScan applies 7-step analysis with CoVe checkpoints to verify Liao (2000) claims against Cheng (2013) meta-data. Theorizer generates hypotheses on optimal mitomycin C timing from Tsirbas (2002) and Anadolu (1998) outcomes.
Frequently Asked Questions
What is mitomycin C's definition in DCR?
Mitomycin C is an antimetabolite applied intraoperatively in DCR to inhibit fibroblast activity and prevent scarring, improving nasolacrimal duct patency (Liao 2000).
What methods evaluate mitomycin C in DCR?
Prospective randomized trials apply 0.2-0.5 mg/mL mitomycin C to ostium edges, assessing anatomical success via patency tests; meta-analyses pool odds ratios (Cheng et al. 2013).
What are key papers on this topic?
Liao (2000, 161 citations) shows long-term benefits in 88 eyes; Cheng et al. (2013, 93 citations) meta-analysis confirms endoscopic efficacy; Anadolu (1998, 139 citations) reports no benefit in small series.
What open problems remain?
Optimal dosage, long-term toxicity, and comparative efficacy in endonasal vs external DCR need larger trials; Jawaheer (2017) highlights technique variability.
Research Nasolacrimal Duct Obstruction Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Mitomycin C in Dacryocystorhinostomy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers